Protein aggregation in bacteria: the thin boundary between functionality and toxicity
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Misfolding and aggregation of proteins have a negative impact on all living organisms. In recent years, aggregation has been studied in detail due to its involvement in neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases, and type II diabetes--all associated with accumulation of amyloid fibrils. This research highlighted the central importance of protein homeostasis, or proteostasis for short, defined as the cellular state in which the proteome is both stable and functional. It implicates an equilibrium between synthesis, folding, trafficking, aggregation, disaggregation and degradation. In accordance with the eukaryotic systems, it has been documented that protein aggregation also reduces fitness of bacterial cells, but although our understanding of the cellular protein quality control systems is perhaps most detailed in bacteria, the use of bacterial proteostasis as a drug target remains little explored. Here we describe protein aggregation as a normal physiological process and its role in bacterial virulence and we shed light on how bacteria defend themselves against the toxic threat of aggregates. We review the impact of aggregates on bacterial viability and look at the ways that bacteria use to maintain a balance between aggregation and functionality. The proteostasis in bacteria can be interrupted via overexpression of proteins, certain antibiotics such as aminoglycosides, as well as antimicrobial peptides--all leading to loss of cell viability. Therefore intracellular protein aggregation and disruption of proteostatic balance in bacteria open up another strategy that should be explored towards the discovery of new antimicrobials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 3×
“Interestingly the functional CsgA polymerization involves the formation of a transient species similar to that produced by other amyloidogenic proteins such as Ab, synuclein, islet amyloid polypeptide, insulin, lysozyme, and polyglutamine, involved in human aggregation diseases (Kayed et al., 2003; Wang et al., 2007).”
BackgroundAdapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495 · cited 1×
“This led to the concept of proteostasis, short for protein homeostasis, defined as the cellular state in which the proteome is both stable and functional (Balch et al., 2008), implicating an equilibrium between synthesis, folding, trafficking, aggregation, disaggregation and degradation.”
BackgroundInherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434 · cited 1×
“It was shown that pre-fibrillar aggregates of proteins that are unrelated to amyloid-related diseases can also be toxic (Bucciantini et al., 2002) together with activation of IbpA/B chaperones (known as protein aggregation markers); recombinant protein aggregates stimulate the levels of SOD…”
BackgroundThe toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962 · cited 4×
“This raises an interesting possibility that the same basic mechanism that can cause neuronal death in e.g. Alzheimer’s disease can be harnessed to combat bacterial infection, provided chemicals can be identified that specifically cause proteostatic collapse in bacteria, but not in the mammalian cells of the host.”
BackgroundInfluentialCommon mechanisms of amyloid oligomer pathogenesis in degenerative disease
Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569 · cited 2×
“Furthermore, since protein function is determined by the three-dimensional structure, the fact that amyloids share generic structures implies that they may also share a common pathological function (Glabe, 2006).”
BackgroundHyun, D.-H., Lee, M., Hattori, N., Kubo, S.-I., Mizuno, Y., Halliwell, B., & Jenner, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200666200 · Cited by 172
Cited by
Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Friedland, R. P. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142841 · Cited by 338
“However, recently it has been shown that functional amyloids are found in yeast, bacteria, rodents, and humans [47] [49].”
BackgroundAdhesins Involved in Attachment to Abiotic Surfaces by Gram-Negative Bacteria
Berne, C., Ducret, A., Hardy, G. G., & Brun, Y. V. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0018-2015 · Cited by 323
ER stress causes widespread protein aggregation and prion formation
Hamdan, N., Kritsiligkou, P., & Grant, C. M. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201612165 · Cited by 85
“It is generally thought that highly expressed and abundant proteins have evolved to be highly soluble and resistant to aggregation (Tartaglia et al., 2007; Castillo et al., 2011; Gsponer and Babu, 2012; Bednarska et al., 2013).”
BackgroundProtein transport across the bacterial plasma membrane by the sec pathway.
Smets, D., Loos, M. S., Karamanou, S., & Economou, A. (2019) · The Protein Journal · doi:10.1007/s10930-019-09841-8 · Cited by 48
Metadata
- Authors
- Bednarska, N. G., Schymkowitz, J., Rousseau, F., & Van Eldere, J.
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2013-09-01
- Volume
- 159
- Issue
- Pt_9
- Pages
- 1795-1806
- ISSN
- 1350-0872 (ISSN-L)
- 1465-2080
- OpenAlex
- W2159878156
- Cited by
- 93
- References
- 6
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.